Champlain Investment Partners »

Caris Life Sciences shares owned by Champlain Investment Partners

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Champlain Investment Partners from 13F filings

Historical chart of Champlain Investment Partners investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Champlain Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Champlain Investment Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $25M 939k 26.98

More positions owned by Champlain Investment Partners

Penumbra (PEN)
Nutanix Cl A (NTNX)
Esab Corporation (ESAB)
Msa Safety Inc equity (MSA)
Confluent Class A Com (CFLT)
Repligen Corporation (RGEN)
Wingstop (WING)
Gitlab Class A Com (GTLB)
Cullen/Frost Bankers (CFR)
Edwards Lifesciences (EW)
IDEX Corporation (IEX)
Cooper Cos (COO)
Msci (MSCI)
Hamilton Lane Cl A (HLNE)
Mettler-Toledo International (MTD)

View all positions for Champlain Investment Partners

Top funds holding Caris Life Sciences

J. H. Whitney Equity Partners VI
Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
PointState Capital
Millennium Management
Neuberger Berman Group
OrbiMed Advisors
BlackRock
UBS Group
Point72 Asset Management
Ameriprise Financial
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences